4 October 2022 ArticlesLeveraging AI to Tackle the Looming Metabolic Syndrome Crisis In this article, we look at how Mesh Bio and MultiOmic Health use AI to transform and improve the lives of metabolic syndrome patients through patient stratification and precision medicine. Read more AI Drug Discovery Mesh Bio Metabolic Syndrome Multiomic Health 8 July 2022 Blog PostUnderstanding the AI-enabled Drug Discovery Landscape An Expert View from Henrietta Bull, science and partnership analyst, and Robert Thong, chief executive, MultiOmic Health. Read more AI Drug Discovery Multiomic Health The Pharma Letter 2/2